Sildenafil equal to bosentan in pulmonary hypertension therapy

被引：0
|
作者：
Barry, H
机构：
来源：
AMERICAN FAMILY PHYSICIAN | 2005年 / 72卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：1330 / +
页数：2
相关论文
共 50 条
  • [41] Acute hemodynamic effect of sildenafil in comparison with inhaled nitric oxide in patients receiving bosentan therapy for pulmonary arterial hypertension
    Galie, Nazzareno
    Michelakis, Evangelos
    Vachiery, Jean-Lue
    Vizza, Carmine Dario
    Meyer, F. J.
    Gruenig, Ekkehard
    CHEST, 2007, 132 (04) : 488S - 488S
  • [42] Sildenafil citrate therapy for pulmonary arterial hypertension
    Izbicki, G
    Rosengarten, D
    Picard, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1091 - 1092
  • [43] Bosentan therapy for neonatal primary pulmonary arterial hypertension
    Demi, M
    Beltramello, C
    Grassi, N
    Meneghetti, G
    Zanardo, V
    PROCEEDINGS OF THE XIX EUROPEAN CONGRESS OF PERINATAL MEDICINE, 2004, : 501 - 506
  • [44] Sildenafil citrate therapy for pulmonary arterial hypertension
    Galiè, N
    Ghofrani, HA
    Torbicki, A
    Barst, RJ
    Rubin, LJ
    Badesch, D
    Fleming, T
    Parpia, T
    Burgess, G
    Branzi, A
    Grimminger, F
    Kurzyna, M
    Simonneau, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20): : 2148 - 2157
  • [45] Clinical and histopathological relationship of sildenafil and bosentan treatments in rats with monocrotaline induced pulmonary hypertension
    Karpuz, D.
    Hallioglu, O.
    Buyukakilli, B.
    Gurgul, S.
    Balli, E.
    Ozeren, M.
    Tasdelen, B.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2017, 118 (09): : 544 - 551
  • [46] Acute Effect of Sildenafil Is Maintained in Pulmonary Arterial Hypertension Patients Chronically Treated With Bosentan
    Hatano, Masaru
    Yao, Atsushi
    Kinugawa, Koichiro
    Hirata, Yasunobu
    Nagai, Ryozo
    INTERNATIONAL HEART JOURNAL, 2011, 52 (04) : 233 - 239
  • [47] Clinical significance of liver toxicity caused by bosentan and sildenafil interaction in pulmonary hypertension treatment
    Ruiz Fuentes, Salvador
    Belda Rustarazo, Susana
    Garcia Fernandez, Cristina
    Gomez Pena, Celia
    Medarde Caballero, Catalina
    Fernandez Lopez, Cristina
    Blanquez Martinez, David
    Caballero Romero, Alvaro
    Moron Romero, Rocio
    Gonzalez Medina, M. Carmen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 214 - 215
  • [48] Sildenafil or Bosentan in Patients Considered Inelegible for Heart Transplantation Because of Severe Pulmonary Hypertension
    Farrero, M.
    Perez-Villa, F.
    Arias, A.
    Stonis, A.
    Castel, A.
    Roig, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S265 - S265
  • [49] Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil
    Mouchaers, K. T. B.
    Schalij, I.
    de Boer, M. A.
    Postmus, P. E.
    van Hinsbergh, V. W. M.
    Amerongen, G. P. van Nieuw
    Noordegraaf, A. Vonk
    van der Laarse, W. J.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (04) : 800 - 807
  • [50] A Case of Chronic Thromboembolic Pulmonary Hypertension Treated Successfully With Bosentan and Sildenafil: A Salvage Regimen
    Sahni, Ashima
    Sukhal, Shashvat
    Ansari, Najamul
    Quesada, Nancy
    CHEST, 2013, 144 (04)
12345